| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,240 | 21,971 | 15,069 | 15,317 | | Cost of Revenue | 2,977 | 3,289 | 2,544 | 3,063 | | | Gross Profit | 14,263 | 18,682 | 12,525 | 12,254 | | | Operating Expenses | | Research Development | 4,299 | 3,683 | 4,994 | 6,747 | | Selling General and Administrative | 7,685 | 7,543 | 7,268 | 8,569 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,279 | 7,456 | 263 | (3,062) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4) | 86 | 42 | 84 | | Earnings Before Interest And Taxes | 2,275 | 7,542 | 305 | (2,978) | | Interest Expense | 49 | 51 | 49 | 31 | | Income Before Tax | 2,226 | 7,491 | 256 | (3,009) | | Income Tax Expense | 162 | 152 | 160 | 134 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,064 | 7,339 | 96 | (3,143) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,064 | 7,339 | 96 | (3,143) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,064 | $7,339 | $96 | ($3,143) |
|
0.51% Nasdaq 
Income Statement
